Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual‐level reanalysis of CORONA and GISSI‐HF

ConclusionThis individual‐level reanalysis of two landmark trials demonstrates a small but statistically significant decreased risk for MI among patients with ischaemic HF randomized to rosuvastatin vs. placebo. Rosuvastatin appears to be effective in preventing MI in ischaemic HF patients not already on statins.

Source: European Journal of Heart Failure - February 1, 2015 Category: Cardiology Authors: Matthew J. Feinstein, Pardeep Jhund, Joseph Kang, Hongyan Ning, Aldo Maggioni, John Wikstrand, John Kjekshus, Luigi Tavazzi, John McMurray, Donald M. Lloyd‐Jones Tags: Original Article Source Type: research